HALLADOR ENERGY CO (HNRG)

US40609P1057 - Common Stock

11.45  -0.29 (-2.47%)

After market: 11.45 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HNRG. HNRG was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. HNRG may be in some trouble as it scores bad on both profitability and health. HNRG does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

In the past year HNRG has reported negative net income.
In the past year HNRG had a positive cash flow from operations.
In multiple years HNRG reported negative net income over the last 5 years.
Each year in the past 5 years HNRG had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.50%, HNRG is doing worse than 83.58% of the companies in the same industry.
HNRG's Return On Equity of -6.36% is on the low side compared to the rest of the industry. HNRG is outperformed by 78.61% of its industry peers.
Industry RankSector Rank
ROA -3.5%
ROE -6.36%
ROIC N/A
ROA(3y)3.22%
ROA(5y)-1.15%
ROE(3y)7.9%
ROE(5y)-2.07%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HNRG's Profit Margin has improved in the last couple of years.
HNRG's Operating Margin has improved in the last couple of years.
The Gross Margin of HNRG (25.49%) is worse than 64.18% of its industry peers.
HNRG's Gross Margin has been stable in the last couple of years.
HNRG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.49%
OM growth 3Y72.2%
OM growth 5Y8.22%
PM growth 3YN/A
PM growth 5Y23.57%
GM growth 3Y2.35%
GM growth 5Y-0.85%

2

2. Health

2.1 Basic Checks

HNRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HNRG has more shares outstanding
HNRG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HNRG has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 1.99 indicates that HNRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.99, HNRG perfoms like the industry average, outperforming 57.21% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that HNRG is not too dependend on debt financing.
HNRG has a better Debt to Equity ratio (0.16) than 72.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 1.99
ROIC/WACCN/A
WACC9.09%

2.3 Liquidity

HNRG has a Current Ratio of 0.58. This is a bad value and indicates that HNRG is not financially healthy enough and could expect problems in meeting its short term obligations.
HNRG has a worse Current ratio (0.58) than 84.08% of its industry peers.
A Quick Ratio of 0.17 indicates that HNRG may have some problems paying its short term obligations.
With a Quick ratio value of 0.17, HNRG is not doing good in the industry: 94.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.17

2

3. Growth

3.1 Past

HNRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.45%.
HNRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 37.97% yearly.
The Revenue for HNRG has decreased by -36.35% in the past year. This is quite bad
The Revenue has been growing by 16.62% on average over the past years. This is quite good.
EPS 1Y (TTM)-122.45%
EPS 3YN/A
EPS 5Y37.97%
EPS Q2Q%-90.91%
Revenue 1Y (TTM)-36.35%
Revenue growth 3Y37.48%
Revenue growth 5Y16.62%
Sales Q2Q%-36.63%

3.2 Future

The Earnings Per Share is expected to decrease by -3.04% on average over the next years.
The Revenue is expected to decrease by -12.30% on average over the next years. This is quite bad
EPS Next Y-126.76%
EPS Next 2Y-70.38%
EPS Next 3Y-3.04%
EPS Next 5YN/A
Revenue Next Year-45.74%
Revenue Next 2Y-23.73%
Revenue Next 3Y-12.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

HNRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 104.42 indicates a quite expensive valuation of HNRG.
Based on the Price/Forward Earnings ratio, HNRG is valued a bit more expensive than the industry average as 75.12% of the companies are valued more cheaply.
HNRG is valuated expensively when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 104.42

4.2 Price Multiples

HNRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HNRG is more expensive than 66.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.9

4.3 Compensation for Growth

HNRG's earnings are expected to decrease with -3.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-70.38%
EPS Next 3Y-3.04%

0

5. Dividend

5.1 Amount

HNRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HALLADOR ENERGY CO

NASDAQ:HNRG (1/6/2025, 4:01:17 PM)

After market: 11.45 0 (0%)

11.45

-0.29 (-2.47%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners50.03%
Inst Owner Change0%
Ins Owners10.4%
Ins Owner Change0.2%
Market Cap488.00M
Analysts82.5
Price Target15.3 (33.62%)
Short Float %5.44%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.83%
Min EPS beat(2)-230.88%
Max EPS beat(2)139.22%
EPS beat(4)2
Avg EPS beat(4)-52.54%
Min EPS beat(4)-230.88%
Max EPS beat(4)139.22%
EPS beat(8)5
Avg EPS beat(8)56.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.76%
Min Revenue beat(2)-17.47%
Max Revenue beat(2)-12.05%
Revenue beat(4)0
Avg Revenue beat(4)-20.76%
Min Revenue beat(4)-41.34%
Max Revenue beat(4)-12.05%
Revenue beat(8)4
Avg Revenue beat(8)0.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.38%
PT rev (3m)66.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-115.79%
EPS NY rev (1m)-5.81%
EPS NY rev (3m)20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.27%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 104.42
P/S 1.15
P/FCF N/A
P/OCF 71.04
P/B 1.53
P/tB 1.53
EV/EBITDA 11.9
EPS(TTM)-0.55
EYN/A
EPS(NY)0.11
Fwd EY0.96%
FCF(TTM)-1.39
FCFYN/A
OCF(TTM)0.16
OCFY1.41%
SpS9.97
BVpS7.48
TBVpS7.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.5%
ROE -6.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.49%
FCFM N/A
ROA(3y)3.22%
ROA(5y)-1.15%
ROE(3y)7.9%
ROE(5y)-2.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y72.2%
OM growth 5Y8.22%
PM growth 3YN/A
PM growth 5Y23.57%
GM growth 3Y2.35%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.07
Cap/Depr 112.67%
Cap/Sales 15.59%
Interest Coverage N/A
Cash Conversion 14.12%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.17
Altman-Z 1.99
F-Score4
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)99.17%
Cap/Depr(5y)84.57%
Cap/Sales(3y)12.71%
Cap/Sales(5y)11.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.45%
EPS 3YN/A
EPS 5Y37.97%
EPS Q2Q%-90.91%
EPS Next Y-126.76%
EPS Next 2Y-70.38%
EPS Next 3Y-3.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-36.35%
Revenue growth 3Y37.48%
Revenue growth 5Y16.62%
Sales Q2Q%-36.63%
Revenue Next Year-45.74%
Revenue Next 2Y-23.73%
Revenue Next 3Y-12.3%
Revenue Next 5YN/A
EBIT growth 1Y-109.21%
EBIT growth 3Y136.74%
EBIT growth 5Y26.21%
EBIT Next Year-77.04%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-153.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.39%
OCF growth 3Y4.16%
OCF growth 5Y2.87%